Skip to main content
search

Down Syndrome Research Opportunities

CURRENT STUDIES

LIFE-DSR Study

210323 life dsr logoThe Longitudinal Investigation for the Enhancement of Down Syndrome Research (LIFE-DSR) is a multi-year, coordinated research study by medical and academic professionals to track and analyze the medical and physical data of 270 adults with Down syndrome.

Learning more about the physiology of people with Down syndrome gives researchers better insight into the connection between Down syndrome and Alzheimer’s disease. LIFE-DSR aims to address the questions of why the rate of Down syndrome-related Alzheimer’s disease is so high, and what therapies and treatments can be developed to prevent it.

Individuals 25 years and older can consider joining the study.

Nova Southeastern University Florida: Impact of the Delivery Style of a Down syndrome Diagnosis on Familial Attitudes

The Nova Southeastern University of Florida research team is looking for parents of a child diagnosed with Down syndrome. The purpose of this study is to find out if the delivery of a Down syndrome diagnosis by a healthcare professional impacts familial attitudes. We hope to use the results of this study to identify the best practices for delivering a Down syndrome diagnosis, so families are well informed on their child’s condition and how to manage it.

 

Who Can Participate? 

  • Parents of a child diagnosed with Down syndrome by a healthcare professional.

What will you do? 

  • You will be taking a one-time, anonymous survey. The survey will take approximately 10 minutes to complete.

What will you receive? 

  • Participation is voluntary and no payment will be provided.

To Participate:
If you have read the above information and voluntarily wish to participate in this research study, please click on the following link for the REDCap survey:

https://redcap.nova.edu/redcap/surveys/?s=N9LJKHW88KAWY893

Questions?

If you have questions, you can contact Palak Bhargav, Rehan Contractor, Dr. Kristi Messer, or Dr. Jose Llanga at 813-406-9225, 813-420-2847, 954-262-1072, and 954-554-5609 respectively.

If you have questions about the study but want to talk to someone who is not a part of the study, please call the Nova Southeastern University Institutional Review Board (IRB) at: (954) 262-5369 or toll-free at: 1-866-499-0790 or email: [email protected].

 

University of Wisconsin: Energy Expenditure & Weight-Related Behavior Study

The University of Wisconsin (UW Milwaukee) research team is looking for families of children aged 5-18 years with Down syndrome in the United States to participate. This study is being conducted to determine how much energy children with Down syndrome use daily. This information will help determine how much children with Down syndrome should eat and drink based on age, gender, and activity level.

Who Can Participate? 

  • Children aged 5-18 years with Down syndrome.

What will you do? 

If you participate in this study, you will have a virtual study visit through Zoom with you and your child. You can do this in your home. Appointments are offered during weekdays and weekends. The study visit will take about 5 hours, but you won’t be on the video call the entire time; there will be breaks. During this study visit, we will work with you to do several activities, including:

  • Taking simple measurements on your child such as height, weight, and waist & hip circumferences
  • Completing surveys
  • Completing activities that involve your child sitting, moving and walking at different paces
  • Completing food recalls, where we ask what your child ate the day before
  • We will also ask your child to drink special water that tracks how much energy they burn. Energy is tracked by collecting urine samples from your child several times after they drink this water.

Before the visit, we will send you two boxes with all of the supplies needed for the study. We pay for shipping, and you can set up a home pick-up to send the supplies back to us.

After the study visit, we will ask you and your child to do a few more things over the next week:

  • We will ask your child to wear a Fitbit on their wrist and another activity monitor on their waist.
  • We will schedule two video calls to complete two more food recalls.
  • We will ask you to collect two more urine samples one week after the initial study visit.
  • We will ask you to send back all materials and urine samples to our lab with a prepaid shipping label.

What will you receive? 

  • Once the activities above are completed and supplies and urine samples are sent back, we will send you a $250 gift card to thank you for your participation in the study.

Register to Participate: Down Syndrome Energy Expenditure and Weight-Related Behaviors Research Study (qualtrics.com)

Questions?

The principal investigator (PI) for this study is Dr. Michele Polfuss, PhD, RN, CPNP-AC/PC, FAAN. Please feel free to contact Michele for more information at: (920) 470-2150 or [email protected] or see this website: https://uwm.edu/nursing/directory/polfuss-michele/ or Linkedin website: www.linkedin.com/in/michele-polfuss-7b421432. 

 

Boston Children's Hospital: BRIDGE Study

Researchers in the Down Syndrome Program & the Labs of Cognitive Neuroscience at Boston Children’s Hospital are recruiting young children between 2 and 5 years old with Down Syndrome (DS) to participate in a study investigating how differences in brain activity affect learning, language, and behavior in DS.

Who Can Participate? 

  • Children aged 24-66 months with Down syndrome.

What will you do? 

  • 2 visits, each one year apart, at the Labs of Cognitive Neuroscience at Boston Children’s Hospital. 
  • Each visit includes clinical and behavioral assessments that will evaluate your child’s thinking, motor skills, language skills, and social communication. In addition, we will measure your child’s brain activity using electroencephalography (EEG).  
  • EEG is a safe and radiation free way to measure brain activity in response to different sounds and pictures.  

What will you receive? 

  • Families will receive a small toy and $50 per visit for participating. We will provide free parking and child-care for siblings. 
  • Families will receive a written report about their child’s development. 

For more information about the BRIDGE study, please call the Down Syndrome Program research team at (617) 919-6809 or email [email protected]. You can also download the flyer below:

Massachusetts General Hospital: Down Syndrome Health Instrument

Researchers at Massachusetts General Hospital Down Syndrome Program are asking primary caregivers to participate in a survey about the health of individuals with Down syndrome (DS).

Although over 200,000 individuals with Down syndrome live in the United States, studies to date have focused on the outcomes apart from health. We need to accurately measure the health of all individuals with DS and there are not similar tools for this population available. Creating such an instrument will provide a barameter of the current state of health for DS and hold use in future research. We are creating an instrument that directly assesses health in DS, the Down syndrome Health Instrument (DHI).

The goal of DHI is to accurately measure the current health of an individual with Down syndrome. To be eligible, you must:

  1. Be the primary caregiver of an individual with Down syndrome (and the individual must be less than 22 years of age and no have mosaic DS).
  2. You, the caregiver, must be at least 18 years of age and be fluent in written and spoken English.
  3. You, the caregiver must be able to read and provide informed consent.

Participation is completely voluntary, and you have the right to withdraw at any time. You will be reimbursed for your time with a $25 gift card.

To receive a link to participate in the survey, or to ask questions about the survey, please email: [email protected].

For more information, download the flyer below:

Boston Children's Hospital: Virtual JASPER Study

Researchers at Boston Children’s Hospital are conducting a study to investigate the impact of JASPER Behavioral Therapy in children with Down syndrome (ages 3-6). Participants and their caregivers will learn about child development, communication and social skills, managing challenging behaviors, and strategies for learning new skills.

There is no compensation for participating in this study. Participants can complete the study from home virtually in approximately 20 weeks.

If you’re interested in participating or have questions about the study, call 857-218-4779 or email: [email protected]. For more information, download the flyer below:

Pediatric Hypoglossal Nerve Stimulation to Address Sleep Apnea

Doctors at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary are studying new ways to treat obstructive sleep apnea in children and young adults with Down syndrome who have persistent obstructive sleep apnea despite prior tonsillectomy.

They are researching how placement of an investigational surgically implanted nerve stimulator for the purpose of treating severe obstructive sleep apnea (OSA) improves the neurocognition and expressive language skills in children with Down syndrome, ages 10-21.

This therapy has already been tested and approved by the FDA for use in adults meeting specific requirements. This research is being conducted at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary by Drs. Hartnick and Skotko.

If you are interested in learning more about this study, and whether or not you/your child would be an appropriate candidate, please contact the research team by calling Dr. Hartnick at (617) 573-4206 or by email at [email protected].

Massachusetts General Hospital: Neuroimaging and EEG Research Study

Researchers at Massachusetts General Hospital are conducting a study to examine the effectiveness of transcranial photobiomodulation (tPBM) on improving language, memory and attention in adults with Down syndrome (ages 18-30).

Compensation: up to $1,245 for participating and a stipend of $525 for cost of transportation. Caregivers will receive a stipend of $525.

If you’re interested in participating call 617-724-4539 and download the flyer below:

transphom-ds_recruitment_flyer_8.13.21

MOSAIC Sleep Apnea Study

Families in Arizona, NM, Utah, and So. California: The University of Arizona is seeking participants for a clinical trial of medications to treat obstructive sleep apnea in children age 6-17 with Down syndrome.

This study will investigate the use a combination of atomoxetine (a medication approved by the FDA in children for the treatment of ADHD) and oxybutynin (a medication approved by the FDA in children for overactive bladder). These medications, which have been shown to treat obstructive sleep apnea in a small study of adults without Down syndrome, are thought to treat obstructive sleep apnea by increasing airway muscle strength, which is known to be lower in children with Down syndrome.

The clinical trial will involve completing a total of 3 sleep studies over 3 months and taking study medications for a total of 2 months. Participants should be within driving distance of the University of Arizona in Tucson.

Children may be eligible if they have a diagnosis of Down syndrome (trisomy 21, but not translocation or mosaicism) and do not have any of the following:

  • currently using and unable to discontinue PAP therapy
  • premature birth < 37 weeks estimated gestational age
  • seizure disorder requiring current use of medications
  • untreated or inadequately treated hypothyroidism
  • history of current, untreated depression
  • history of liver disease

If you would like more information about the study, please contact Silvia Lopez at [email protected] for further information. Participants will be compensated for their time. This study has been approved by the University of Arizona Institutional Review Board.

The Picower Institute for Learning and Memory at MIT: Light and Sound Stimulation Study

The Picower Institute for Learning and Memory at MIT is studying how the brain responds to light and sound stimulation in Individuals with Down syndrome.

People with Down syndrome, ages 25-65, who are interested in a one-time study visit (at MIT in Cambridge, MA) are invited to learn more.

For more information, download the flyer below:

mit_ds_advert_09.2021

Lurie Center for Autism Fluoxetine Study (Depression)

020723 Image FB

The Lurie Center for Autism is conducting a study designed to evaluate the effects of fluoxetine in individuals with Down syndrome. Participants must be adults between 18 to 45 years of age with DS who are experiencing symptoms of depression.

Participants will receive all study related evaluations at no charge. For additional information about study requirements and study procedures, please contact Dr. Robyn Thom’s study staff at (781) 860-1711 or [email protected].

OPEN SURVEYS

No digital surveys are open at the moment, but check back soon for newly released opportunities to share your experience and provide input!

READY FOR RESEARCH?

Learn more about
Down syndrome
Research

READY TO MAKE A DIFFERENCE?

Join the fight
for equal access
to therapies
Close Menu